YU47880B - Protein i postupak za dobijanje proteina - Google Patents
Protein i postupak za dobijanje proteinaInfo
- Publication number
- YU47880B YU47880B YU113889A YU113889A YU47880B YU 47880 B YU47880 B YU 47880B YU 113889 A YU113889 A YU 113889A YU 113889 A YU113889 A YU 113889A YU 47880 B YU47880 B YU 47880B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- protein
- procedure
- obtaining
- dna strand
- accessions
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 8
- 108090000623 proteins and genes Proteins 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 3
- 108020004414 DNA Proteins 0.000 abstract 2
- 102000053602 DNA Human genes 0.000 abstract 2
- 241000223924 Eimeria Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/455—Eimeria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PROTEIN I POSTUPAK ZA DOBIJANJE PROTEINA, protein koji ima jednu ili više antigenskih determinanti za površinski antigen Eimeria, naznačen time, što ima jedan od nizova amino kiselina prikazanih na slikama 17, 19 ili 21, ili je njegovo funkcionalni ekvivalent i specifično se vezuje za jedno ili više monoklonskih antitela deponovanih kod Američke Kolekcije Tipova Kultura i označenih pristupima br. HB 9707 do HB 9710 i HB 9712. Postupak za dobivanje proteina prema zahtevu 1, naznačen ti me, što obuhvata: a) kultivisanje organizma domaćina transformisanog rekom-binantnim vektorom koji obuhvata DNA niz koji kodira pomenuti protein pod uslovima u kojima je ovaj DNA niz eksprimiran, i b) izolovanje proteina iz ove kulture. Prijava sadrži još 1 nezavisan i 11 zavisnih zahteva.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20272188A | 1988-06-03 | 1988-06-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
YU113889A YU113889A (en) | 1991-10-31 |
YU47880B true YU47880B (sh) | 1996-05-20 |
Family
ID=22750986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU113889A YU47880B (sh) | 1988-06-03 | 1989-06-02 | Protein i postupak za dobijanje proteina |
Country Status (22)
Country | Link |
---|---|
US (2) | US5661015A (sh) |
EP (1) | EP0344808B1 (sh) |
JP (1) | JP3051130B2 (sh) |
KR (1) | KR0156545B1 (sh) |
CN (3) | CN1040126C (sh) |
AR (1) | AR241942A1 (sh) |
AT (1) | ATE120489T1 (sh) |
AU (1) | AU635704B2 (sh) |
CA (1) | CA1340538C (sh) |
DE (1) | DE68921923T2 (sh) |
DK (1) | DK272889A (sh) |
ES (1) | ES2070866T3 (sh) |
FI (1) | FI101453B (sh) |
HU (1) | HU212505B (sh) |
IE (1) | IE67544B1 (sh) |
IL (1) | IL90489A0 (sh) |
MC (1) | MC2039A1 (sh) |
NO (1) | NO303876B1 (sh) |
NZ (1) | NZ229377A (sh) |
PT (1) | PT90727B (sh) |
YU (1) | YU47880B (sh) |
ZA (1) | ZA893740B (sh) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5174993A (en) * | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
US5279960A (en) * | 1984-07-05 | 1994-01-18 | Enzon Corp. | 25 KD coccidial antigen of eimeria tenella |
US5273901A (en) * | 1984-07-05 | 1993-12-28 | Enzon Corp. | Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b |
US5824656A (en) * | 1988-01-15 | 1998-10-20 | Merck & Co., Inc. | Recombinant and native group B eimeria tenella immunogens useful as coccidiosis vaccines |
DE68927350T2 (de) * | 1988-07-05 | 1997-04-24 | British Tech Group Usa | Gentechnologisch hergestellter coccidiose-impfstoff |
ZA902147B (en) * | 1989-03-28 | 1990-12-28 | Akzo Nv | Coccidiosis vaccine |
ATE94208T1 (de) * | 1989-06-21 | 1993-09-15 | Akzo Nv | Eimeria tenella-vakzin. |
ZA9010461B (en) * | 1990-01-26 | 1991-10-30 | Hoffmann La Roche | Recombinant coccidiosis vaccines-5-7 eimeria surface antigen |
JPH07500483A (ja) * | 1991-03-14 | 1995-01-19 | ブリティッシュ・テクノロジー・グループ・ユーエスエイ・インコーポレーテッド | 組換え体抗コクシジアワクチン |
US6008342A (en) * | 1991-07-12 | 1999-12-28 | Roche Vitamins Inc. | DNA encoding eimeria antigen |
US5403581A (en) * | 1991-07-12 | 1995-04-04 | Hoffmann-La Roche Inc. | Coccidiosis vaccines |
JP3534774B2 (ja) | 1995-06-07 | 2004-06-07 | ファイザー・インク | コクシジウム症に対する卵内予防接種 |
US6500438B2 (en) | 1995-06-07 | 2002-12-31 | Pfizer Incorporated | In ovo vaccination against coccidiosis |
ES2253746T3 (es) * | 1995-07-03 | 2006-06-01 | Akzo Nobel N.V. | Vacuna contra la coccidiosis aviar. |
AU2590997A (en) * | 1996-03-29 | 1997-10-22 | Life Technologies, Inc. | Method for increasing viability and transformation efficiency of bacteria during storage at low temperatures |
US6632923B1 (en) * | 1996-11-27 | 2003-10-14 | Boston Heart Foundation, Inc. | Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
US6627205B2 (en) | 1997-12-01 | 2003-09-30 | Pfizer Incorporated | Ovo vaccination against coccidiosis |
US6984378B1 (en) | 1999-02-26 | 2006-01-10 | Pfizer, Inc. | Method for the purification, recovery, and sporulation of cysts and oocysts |
ZA200400479B (en) * | 2001-07-06 | 2006-05-31 | Abic Biolog Lab Teva | Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use |
KR100490669B1 (ko) * | 2001-08-30 | 2005-05-19 | (주)아비코아생명공학연구소 | 조류 콕시듐증을 유발하는 에이메리아 종의 포자소체 표면항원에 대한 scFv 재조합 항체 |
WO2003020917A1 (en) | 2001-08-30 | 2003-03-13 | Embrex, Inc. | Improved methods for producing oocysts |
JP3995541B2 (ja) * | 2002-06-28 | 2007-10-24 | 株式会社ゲン・コーポレーション | 抗鶏コクシジウム症組成物 |
DE10330235A1 (de) * | 2003-07-04 | 2005-01-20 | Bayer Healthcare Ag | Neues Eimeria Gen und Protein sowie deren Verwendung |
US7348401B2 (en) * | 2003-09-10 | 2008-03-25 | Innate Biotech, Inc. | Peptides that inhibit complement activation |
DE602005021873D1 (de) * | 2004-03-12 | 2010-07-29 | Univ Georgia | Neues impfstoffadjuvans und dessen herstellung und verwendung |
US7087425B2 (en) * | 2004-03-31 | 2006-08-08 | Embrex, Inc. | Method of purifying oocysts using enzymatic digestion of fecal debris |
US20110078828A1 (en) * | 2004-09-10 | 2011-03-31 | Guardian Biotechnologies Inc. | Multi epitope vaccine for poultry |
DE602005003429T2 (de) * | 2004-12-01 | 2008-10-02 | Zeon Corp. | Kodierende DNS für ein Eimeria Apical Membran Antigen 1 und dessen Verwendungen |
CN100398156C (zh) * | 2005-11-23 | 2008-07-02 | 南京农业大学 | 用于预防鸡球虫病的免疫调节型dna疫苗 |
US20080194006A1 (en) * | 2007-02-08 | 2008-08-14 | Embrex, Inc. | Methods of releasing sporocysts from oocysts using controlled shear forces |
US11701683B2 (en) | 2010-12-22 | 2023-07-18 | The Procter & Gamble Company | Methods for foil stamping parts having asymmetrical edges |
US10758601B2 (en) | 2016-12-22 | 2020-09-01 | Intervet Inc. | Eimeria vaccine with improved efficacy |
WO2020243240A1 (en) * | 2019-05-28 | 2020-12-03 | Case Western Reserve University | Compositions and methods for preserving dna methylation |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4237224A (en) | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
DE2814039C3 (de) | 1978-03-31 | 1981-02-19 | Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig | Verfahren zur Herstellung von Hybrid-Bakterien |
EP0135073A3 (en) * | 1983-08-19 | 1987-05-27 | American Cyanamid Company | Antigens and monoclonal antibodies reactive against merozites of eimeria spp. |
US4650676A (en) | 1983-08-19 | 1987-03-17 | American Cyanamid Company | Antigens and monoclonal antibodies reactive against merozoites of Eimeria spp. |
US4710377A (en) * | 1983-08-19 | 1987-12-01 | American Cyanamid Company | Antigens and monoclonal antibodies reactive against sporozoites of Eimeria spp. |
EP0135712A3 (en) * | 1983-08-19 | 1987-05-27 | American Cyanamid Company | Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp. |
US4874705A (en) * | 1985-05-16 | 1989-10-17 | Solvay & Cie, S.A. | DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella |
US5187080A (en) * | 1984-06-05 | 1993-02-16 | Solvay & Cie S.A. | DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella |
CA1340520C (en) * | 1984-06-05 | 1999-05-04 | Karel Z. Newman Jr. | Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix |
US4639372A (en) | 1984-06-29 | 1987-01-27 | Merck & Co., Inc. | Coccidiosis vaccine |
WO1986000528A1 (en) * | 1984-07-05 | 1986-01-30 | Genex Corporation | Cloned gene and method for making and using the same |
US5273901A (en) * | 1984-07-05 | 1993-12-28 | Enzon Corp. | Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b |
ES2109254T3 (es) * | 1985-12-03 | 1998-01-16 | Dimminaco Ag Sa Ltd | Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis. |
EP0241139A3 (en) * | 1986-03-13 | 1989-04-19 | Merck & Co. Inc. | Anti-idiotypic vaccine for coccidiosis |
US5496550A (en) * | 1986-08-14 | 1996-03-05 | Chilwalner | Method of reducing the output of Eimeria oocysts from a newborn chick |
ATE145245T1 (de) * | 1987-03-06 | 1996-11-15 | Amgen Boulder Inc | Polypeptide zur verwendung bei der diagnose von kokkidien-infektion und rekombinant-dns, verfahren zur herstellung derselben |
EP0315073A2 (en) * | 1987-11-02 | 1989-05-10 | Matsushita Electric Industrial Co., Ltd. | A composition for pattern forming materials |
NZ227595A (en) * | 1988-01-15 | 1991-11-26 | Merck & Co Inc | Recombinant production of eimeria tenella antigens and their use |
NZ227597A (en) * | 1988-01-15 | 1991-11-26 | Merck & Co Inc | Eimeria tenella group b immunogens and their production |
AU620366B2 (en) * | 1988-02-12 | 1992-02-20 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated response and method of producing the same |
DE3926461A1 (de) * | 1989-07-15 | 1991-01-24 | Suttner Gmbh & Co Kg | Ventilpistole, insbesondere fuer ein hochdruckreinigungsgeraet |
-
1989
- 1989-05-18 ZA ZA893740A patent/ZA893740B/xx unknown
- 1989-06-01 IL IL90489A patent/IL90489A0/xx unknown
- 1989-06-01 AR AR89314066A patent/AR241942A1/es active
- 1989-06-01 NZ NZ229377A patent/NZ229377A/en unknown
- 1989-06-02 AT AT89110056T patent/ATE120489T1/de not_active IP Right Cessation
- 1989-06-02 AU AU36016/89A patent/AU635704B2/en not_active Ceased
- 1989-06-02 DK DK272889A patent/DK272889A/da not_active Application Discontinuation
- 1989-06-02 HU HU892814A patent/HU212505B/hu not_active IP Right Cessation
- 1989-06-02 PT PT90727A patent/PT90727B/pt not_active IP Right Cessation
- 1989-06-02 NO NO892251A patent/NO303876B1/no not_active IP Right Cessation
- 1989-06-02 MC MC892053A patent/MC2039A1/xx unknown
- 1989-06-02 CA CA000601631A patent/CA1340538C/en not_active Expired - Fee Related
- 1989-06-02 FI FI892714A patent/FI101453B/fi not_active IP Right Cessation
- 1989-06-02 DE DE68921923T patent/DE68921923T2/de not_active Expired - Fee Related
- 1989-06-02 EP EP89110056A patent/EP0344808B1/en not_active Expired - Lifetime
- 1989-06-02 YU YU113889A patent/YU47880B/sh unknown
- 1989-06-02 ES ES89110056T patent/ES2070866T3/es not_active Expired - Lifetime
- 1989-06-03 CN CN89104278A patent/CN1040126C/zh not_active Expired - Fee Related
- 1989-06-03 KR KR1019890007661A patent/KR0156545B1/ko not_active IP Right Cessation
- 1989-06-03 JP JP1140268A patent/JP3051130B2/ja not_active Expired - Lifetime
- 1989-06-12 IE IE181289A patent/IE67544B1/en not_active IP Right Cessation
-
1991
- 1991-12-20 US US07/812,349 patent/US5661015A/en not_active Expired - Lifetime
-
1997
- 1997-09-22 CN CN97119228A patent/CN1076204C/zh not_active Expired - Fee Related
- 1997-09-22 CN CN97118698A patent/CN1077438C/zh not_active Expired - Fee Related
-
2002
- 2002-10-09 US US10/267,430 patent/US20030175311A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU47880B (sh) | Protein i postupak za dobijanje proteina | |
CA2180425A1 (en) | Purified primate ctla-8 antigens and related reagents | |
CA2406240C (en) | Hcv anti-core monoclonal antibodies | |
ES8706964A1 (es) | Un procedimiento para fraccionar anticuerpos de suero. | |
DE60039596D1 (de) | Verfahren zur herstellung von monoklonalen antikörpern | |
AU1273695A (en) | Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications | |
HUP9802401A2 (hu) | Az emberi gp39-protein különböző epitópjaira specifikus monoklonális antitestek, valamint eljárások az ilyen antitestek diagnosztikai és terápiás alkalmazására | |
HUP0202796A2 (en) | Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens | |
JPWO2021181994A5 (sh) | ||
PT100637A (pt) | Receptor ctla4 e metodos para a sua utilizacao | |
PT97159A (pt) | Processo para a preparacao de uma proteina do antigenio de superficie da hepatite b ou de um seu fragmento e processo para a preparacao de uma vacina | |
CA2399790A1 (en) | Cd40 ligand adjuvant for respiratory syncytial virus | |
WO2020132091A3 (en) | Antibodies that neutralize hepatitis b virus and uses thereof | |
HUP0103650A2 (hu) | Vírusburok-proteinek epitópjai és az ellenük termelt ellenanyagok alkalmazása HCV-vírusantigén gazdaszövetből történő kimutatására | |
Jemmerson et al. | Mapping antigenic sites on proteins: Implications for the design of synthetic vaccines. | |
DE69531311D1 (de) | Monoklonale antikörper spezifisch für endprodukte der fortgeschrittenen glycosylation in biologischen proben | |
ES8404186A1 (es) | "un procedimiento para obtener al menos un polipeptido que presenta la antigenicidad de los antigenos e del virus de la hepatitis b". | |
CN105229036A (zh) | 在疏水性相互作用位点内引入了静电相互作用的蛋白及其制备方法 | |
DK430583D0 (da) | Polypeptider samt deres fremstilling og anvendelse | |
ATE298798T1 (de) | Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin | |
WO1996021734A3 (en) | P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods | |
WO1999013907A3 (en) | Methods to improve immunogenicity of antigens and specificity of antibodies | |
ATE101345T1 (de) | Selektive entfernung von immunkomplexen. | |
RU2004108115A (ru) | Рекомбинантные антитела и композиции, а также способы их создания и использования | |
DE69737323D1 (de) | Adhesin aus heliobacter pylori, welches an blutgruppenantigene bindet |